Drug Shortage Report for AVAPRO

Last updated on 2021-06-19 History
Report ID 139790
Drug Identification Number 02237923
Brand name AVAPRO
Common or Proper name Avapro
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) IRBESARTAN
Strength(s) 75MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 90
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2021-05-21
Estimated end date 2021-08-02
Actual end date 2021-06-18
Shortage status Resolved
Updated date 2021-06-19
Company comments Delay in testing. Availability dates at individual distributor warehouses may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-05-21 English Compare
v2 2021-05-21 French Compare
v3 2021-05-22 English Compare
v4 2021-06-18 English Compare
v5 2021-06-18 French Compare
v6 2021-06-19 English Compare

Showing 1 to 6 of 6